Structure

Physi-Chem Properties

Molecular Weight:  466.15
Volume:  441.636
LogP:  0.667
LogD:  0.553
LogS:  -3.231
# Rotatable Bonds:  8
TPSA:  186.37
# H-Bond Aceptor:  11
# H-Bond Donor:  7
# Rings:  3
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.202
Synthetic Accessibility Score:  3.85
Fsp3:  0.409
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.416
MDCK Permeability:  6.62936145090498e-06
Pgp-inhibitor:  0.018
Pgp-substrate:  0.124
Human Intestinal Absorption (HIA):  0.872
20% Bioavailability (F20%):  0.019
30% Bioavailability (F30%):  0.997

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.09
Plasma Protein Binding (PPB):  90.58963012695312%
Volume Distribution (VD):  0.702
Pgp-substrate:  7.116474151611328%

ADMET: Metabolism

CYP1A2-inhibitor:  0.387
CYP1A2-substrate:  0.073
CYP2C19-inhibitor:  0.041
CYP2C19-substrate:  0.062
CYP2C9-inhibitor:  0.038
CYP2C9-substrate:  0.511
CYP2D6-inhibitor:  0.406
CYP2D6-substrate:  0.297
CYP3A4-inhibitor:  0.061
CYP3A4-substrate:  0.049

ADMET: Excretion

Clearance (CL):  10.873
Half-life (T1/2):  0.87

ADMET: Toxicity

hERG Blockers:  0.159
Human Hepatotoxicity (H-HT):  0.07
Drug-inuced Liver Injury (DILI):  0.711
AMES Toxicity:  0.467
Rat Oral Acute Toxicity:  0.028
Maximum Recommended Daily Dose:  0.011
Skin Sensitization:  0.927
Carcinogencity:  0.074
Eye Corrosion:  0.003
Eye Irritation:  0.195
Respiratory Toxicity:  0.027

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC300537

Natural Product ID:  NPC300537
Common Name*:   2',3,4,6'-Tetrahydroxy-4'-Methoxydihydrochalcone 2'-O-Beta-D-Glucopyranoside
IUPAC Name:   3-(3,4-dihydroxyphenyl)-1-[2-hydroxy-4-methoxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]propan-1-one
Synonyms:   3-hydroxyasebotin
Standard InCHIKey:  IWJPQQXPWSVXAG-MIUGBVLSSA-N
Standard InCHI:  InChI=1S/C22H26O11/c1-31-11-7-15(27)18(13(25)5-3-10-2-4-12(24)14(26)6-10)16(8-11)32-22-21(30)20(29)19(28)17(9-23)33-22/h2,4,6-8,17,19-24,26-30H,3,5,9H2,1H3/t17-,19-,20+,21-,22-/m1/s1
SMILES:  OC[C@H]1O[C@@H](Oc2cc(OC)cc(c2C(=O)CCc2ccc(c(c2)O)O)O)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL480475
PubChem CID:   11340276
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO13961 Pieris japonica Species Ericaceae Eukaryota leaves n.a. n.a. PMID[15787442]
NPO13961 Pieris japonica Species Ericaceae Eukaryota n.a. leaf n.a. PMID[15787442]
NPO13961 Pieris japonica Species Ericaceae Eukaryota Leaves n.a. n.a. PMID[31809052]
NPO13961 Pieris japonica Species Ericaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO13961 Pieris japonica Species Ericaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO13961 Pieris japonica Species Ericaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 23.95 10'-3cpm PMID[497361]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 22.1 10'-3cpm PMID[497361]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 22.16 10'-3cpm PMID[497361]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 33.03 10'-3cpm PMID[497361]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 71.45 10'-3cpm PMID[497361]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 66.72 10'-3cpm PMID[497361]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC300537 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC127782
0.9808 High Similarity NPC236934
0.9808 High Similarity NPC5778
0.9806 High Similarity NPC29830
0.9806 High Similarity NPC19709
0.9745 High Similarity NPC229729
0.9744 High Similarity NPC165720
0.9744 High Similarity NPC311830
0.9744 High Similarity NPC22832
0.9742 High Similarity NPC189142
0.9742 High Similarity NPC473043
0.9742 High Similarity NPC77660
0.9684 High Similarity NPC43587
0.9684 High Similarity NPC52382
0.9684 High Similarity NPC229687
0.9684 High Similarity NPC270578
0.9682 High Similarity NPC210073
0.9682 High Similarity NPC115674
0.9679 High Similarity NPC222936
0.9679 High Similarity NPC243930
0.9679 High Similarity NPC88023
0.9679 High Similarity NPC191306
0.9679 High Similarity NPC168822
0.9679 High Similarity NPC88043
0.9679 High Similarity NPC284960
0.9679 High Similarity NPC309025
0.9679 High Similarity NPC270335
0.9623 High Similarity NPC183357
0.9623 High Similarity NPC21190
0.9623 High Similarity NPC44328
0.9623 High Similarity NPC78734
0.9623 High Similarity NPC150767
0.9623 High Similarity NPC212748
0.9623 High Similarity NPC177731
0.9623 High Similarity NPC22195
0.9623 High Similarity NPC79056
0.9623 High Similarity NPC231194
0.9623 High Similarity NPC105095
0.9623 High Similarity NPC51326
0.962 High Similarity NPC52550
0.962 High Similarity NPC116745
0.962 High Similarity NPC45400
0.962 High Similarity NPC317489
0.962 High Similarity NPC127546
0.962 High Similarity NPC477502
0.962 High Similarity NPC223424
0.962 High Similarity NPC84362
0.962 High Similarity NPC173637
0.962 High Similarity NPC160156
0.962 High Similarity NPC92565
0.9618 High Similarity NPC277205
0.9563 High Similarity NPC261254
0.9563 High Similarity NPC256760
0.9563 High Similarity NPC235575
0.9563 High Similarity NPC205076
0.9563 High Similarity NPC301683
0.9563 High Similarity NPC307518
0.9563 High Similarity NPC48773
0.956 High Similarity NPC170675
0.956 High Similarity NPC93337
0.956 High Similarity NPC223747
0.956 High Similarity NPC210042
0.956 High Similarity NPC105025
0.956 High Similarity NPC472381
0.956 High Similarity NPC293629
0.956 High Similarity NPC105283
0.956 High Similarity NPC120099
0.956 High Similarity NPC209296
0.956 High Similarity NPC469931
0.956 High Similarity NPC225434
0.956 High Similarity NPC58053
0.956 High Similarity NPC475942
0.956 High Similarity NPC45638
0.956 High Similarity NPC201292
0.956 High Similarity NPC195257
0.956 High Similarity NPC472383
0.956 High Similarity NPC471457
0.956 High Similarity NPC219904
0.956 High Similarity NPC95855
0.956 High Similarity NPC203050
0.956 High Similarity NPC186807
0.956 High Similarity NPC112755
0.956 High Similarity NPC226294
0.9557 High Similarity NPC197285
0.9557 High Similarity NPC88789
0.9557 High Similarity NPC21100
0.9557 High Similarity NPC113968
0.9557 High Similarity NPC277174
0.9557 High Similarity NPC276222
0.9557 High Similarity NPC73855
0.9557 High Similarity NPC274618
0.9557 High Similarity NPC145038
0.9557 High Similarity NPC118284
0.9557 High Similarity NPC135599
0.9557 High Similarity NPC281131
0.9557 High Similarity NPC8856
0.9557 High Similarity NPC179950
0.9557 High Similarity NPC56077
0.9557 High Similarity NPC253662
0.9557 High Similarity NPC308404
0.9557 High Similarity NPC328940
0.9551 High Similarity NPC182045
0.9542 High Similarity NPC106625
0.9503 High Similarity NPC236191
0.9503 High Similarity NPC208668
0.9503 High Similarity NPC239549
0.9503 High Similarity NPC51774
0.95 High Similarity NPC218488
0.95 High Similarity NPC474434
0.95 High Similarity NPC224462
0.95 High Similarity NPC206123
0.95 High Similarity NPC95866
0.95 High Similarity NPC44558
0.95 High Similarity NPC116864
0.95 High Similarity NPC471416
0.95 High Similarity NPC34287
0.95 High Similarity NPC244776
0.95 High Similarity NPC67105
0.95 High Similarity NPC105511
0.9497 High Similarity NPC93099
0.9497 High Similarity NPC58716
0.9497 High Similarity NPC146792
0.9497 High Similarity NPC325555
0.9497 High Similarity NPC48640
0.9497 High Similarity NPC226304
0.9497 High Similarity NPC149244
0.9497 High Similarity NPC265530
0.9497 High Similarity NPC45618
0.9494 High Similarity NPC240431
0.9494 High Similarity NPC19388
0.9494 High Similarity NPC55786
0.9487 High Similarity NPC110349
0.9481 High Similarity NPC99233
0.9477 High Similarity NPC121001
0.9477 High Similarity NPC259182
0.9444 High Similarity NPC294629
0.9441 High Similarity NPC254540
0.9441 High Similarity NPC47140
0.9441 High Similarity NPC153755
0.9441 High Similarity NPC476405
0.9441 High Similarity NPC172807
0.9441 High Similarity NPC472386
0.9441 High Similarity NPC203259
0.9441 High Similarity NPC33054
0.9441 High Similarity NPC471748
0.9441 High Similarity NPC176740
0.9441 High Similarity NPC190003
0.9441 High Similarity NPC117260
0.9441 High Similarity NPC67134
0.9441 High Similarity NPC471725
0.9441 High Similarity NPC245452
0.9441 High Similarity NPC175107
0.9441 High Similarity NPC211594
0.9441 High Similarity NPC267254
0.9441 High Similarity NPC155877
0.9441 High Similarity NPC134532
0.9437 High Similarity NPC86008
0.9437 High Similarity NPC227508
0.9437 High Similarity NPC183036
0.9434 High Similarity NPC67037
0.9434 High Similarity NPC255615
0.9434 High Similarity NPC254306
0.943 High Similarity NPC94777
0.9423 High Similarity NPC73511
0.9419 High Similarity NPC206378
0.9419 High Similarity NPC261866
0.9419 High Similarity NPC127406
0.9416 High Similarity NPC18727
0.9383 High Similarity NPC88560
0.9383 High Similarity NPC25724
0.9383 High Similarity NPC21666
0.9383 High Similarity NPC101026
0.9383 High Similarity NPC169977
0.9383 High Similarity NPC472993
0.9383 High Similarity NPC42773
0.9383 High Similarity NPC175230
0.9383 High Similarity NPC4390
0.9383 High Similarity NPC204693
0.9383 High Similarity NPC24043
0.9383 High Similarity NPC45522
0.9383 High Similarity NPC172033
0.9379 High Similarity NPC156869
0.9379 High Similarity NPC72249
0.9379 High Similarity NPC20505
0.9379 High Similarity NPC155763
0.9379 High Similarity NPC259896
0.9379 High Similarity NPC149011
0.9379 High Similarity NPC235260
0.9379 High Similarity NPC29958
0.9379 High Similarity NPC254855
0.9379 High Similarity NPC255157
0.9379 High Similarity NPC245014
0.9379 High Similarity NPC285197
0.9379 High Similarity NPC136042
0.9379 High Similarity NPC84265
0.9379 High Similarity NPC282987
0.9379 High Similarity NPC204937
0.9379 High Similarity NPC67326
0.9375 High Similarity NPC135345
0.9375 High Similarity NPC275454

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC300537 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9623 High Similarity NPD7074 Phase 3
0.956 High Similarity NPD7054 Approved
0.95 High Similarity NPD7472 Approved
0.9497 High Similarity NPD3818 Discontinued
0.9441 High Similarity NPD6797 Phase 2
0.9383 High Similarity NPD7251 Discontinued
0.9359 High Similarity NPD4381 Clinical (unspecified phase)
0.9351 High Similarity NPD1934 Approved
0.929 High Similarity NPD2393 Clinical (unspecified phase)
0.9207 High Similarity NPD4338 Clinical (unspecified phase)
0.9207 High Similarity NPD7808 Phase 3
0.913 High Similarity NPD6168 Clinical (unspecified phase)
0.913 High Similarity NPD6166 Phase 2
0.913 High Similarity NPD6167 Clinical (unspecified phase)
0.8963 High Similarity NPD7804 Clinical (unspecified phase)
0.8924 High Similarity NPD2801 Approved
0.8831 High Similarity NPD1511 Approved
0.8812 High Similarity NPD4868 Clinical (unspecified phase)
0.8802 High Similarity NPD6559 Discontinued
0.875 High Similarity NPD3817 Phase 2
0.8734 High Similarity NPD4380 Phase 2
0.8718 High Similarity NPD1512 Approved
0.8696 High Similarity NPD3882 Suspended
0.8642 High Similarity NPD7075 Discontinued
0.8562 High Similarity NPD1552 Clinical (unspecified phase)
0.8562 High Similarity NPD1550 Clinical (unspecified phase)
0.8506 High Similarity NPD1549 Phase 2
0.8457 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8418 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8412 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8395 Intermediate Similarity NPD6801 Discontinued
0.8344 Intermediate Similarity NPD7819 Suspended
0.8313 Intermediate Similarity NPD5494 Approved
0.8293 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8261 Intermediate Similarity NPD1653 Approved
0.8258 Intermediate Similarity NPD2796 Approved
0.8239 Intermediate Similarity NPD6799 Approved
0.8221 Intermediate Similarity NPD7411 Suspended
0.8214 Intermediate Similarity NPD6232 Discontinued
0.8199 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8194 Intermediate Similarity NPD1510 Phase 2
0.8187 Intermediate Similarity NPD5844 Phase 1
0.8182 Intermediate Similarity NPD5402 Approved
0.8176 Intermediate Similarity NPD7473 Discontinued
0.817 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.817 Intermediate Similarity NPD1613 Approved
0.8155 Intermediate Similarity NPD6959 Discontinued
0.8155 Intermediate Similarity NPD7199 Phase 2
0.8121 Intermediate Similarity NPD1465 Phase 2
0.8086 Intermediate Similarity NPD5403 Approved
0.8075 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8052 Intermediate Similarity NPD1240 Approved
0.8049 Intermediate Similarity NPD6599 Discontinued
0.8045 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8036 Intermediate Similarity NPD6234 Discontinued
0.8023 Intermediate Similarity NPD7228 Approved
0.7963 Intermediate Similarity NPD5401 Approved
0.7955 Intermediate Similarity NPD8312 Approved
0.7955 Intermediate Similarity NPD8313 Approved
0.7953 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7952 Intermediate Similarity NPD37 Approved
0.7949 Intermediate Similarity NPD1607 Approved
0.7943 Intermediate Similarity NPD7685 Pre-registration
0.7935 Intermediate Similarity NPD943 Approved
0.7919 Intermediate Similarity NPD3751 Discontinued
0.7917 Intermediate Similarity NPD4967 Phase 2
0.7917 Intermediate Similarity NPD4966 Approved
0.7917 Intermediate Similarity NPD4965 Approved
0.7908 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7907 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7901 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD3787 Discontinued
0.7862 Intermediate Similarity NPD7266 Discontinued
0.7857 Intermediate Similarity NPD3027 Phase 3
0.7843 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7833 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7826 Intermediate Similarity NPD4628 Phase 3
0.7826 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7812 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD7584 Approved
0.7771 Intermediate Similarity NPD230 Phase 1
0.7771 Intermediate Similarity NPD1933 Approved
0.7765 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7746 Intermediate Similarity NPD3926 Phase 2
0.7742 Intermediate Similarity NPD6780 Approved
0.7742 Intermediate Similarity NPD6782 Approved
0.7742 Intermediate Similarity NPD6779 Approved
0.7742 Intermediate Similarity NPD6778 Approved
0.7742 Intermediate Similarity NPD6781 Approved
0.7742 Intermediate Similarity NPD6777 Approved
0.7742 Intermediate Similarity NPD6776 Approved
0.7719 Intermediate Similarity NPD919 Approved
0.7716 Intermediate Similarity NPD3750 Approved
0.7706 Intermediate Similarity NPD7768 Phase 2
0.7696 Intermediate Similarity NPD8151 Discontinued
0.7692 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD8455 Phase 2
0.7688 Intermediate Similarity NPD2935 Discontinued
0.7688 Intermediate Similarity NPD1551 Phase 2
0.7669 Intermediate Similarity NPD6190 Approved
0.7661 Intermediate Similarity NPD3749 Approved
0.7654 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7636 Intermediate Similarity NPD2533 Approved
0.7636 Intermediate Similarity NPD2534 Approved
0.7636 Intermediate Similarity NPD2532 Approved
0.763 Intermediate Similarity NPD1247 Approved
0.7619 Intermediate Similarity NPD7435 Discontinued
0.7547 Intermediate Similarity NPD447 Suspended
0.7546 Intermediate Similarity NPD2800 Approved
0.7542 Intermediate Similarity NPD7240 Approved
0.7526 Intermediate Similarity NPD7696 Phase 3
0.7526 Intermediate Similarity NPD7697 Approved
0.7526 Intermediate Similarity NPD7783 Phase 2
0.7526 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7526 Intermediate Similarity NPD7698 Approved
0.7487 Intermediate Similarity NPD7870 Phase 2
0.7487 Intermediate Similarity NPD7871 Phase 2
0.7486 Intermediate Similarity NPD5953 Discontinued
0.7474 Intermediate Similarity NPD6823 Phase 2
0.7473 Intermediate Similarity NPD6535 Approved
0.7473 Intermediate Similarity NPD6534 Approved
0.7469 Intermediate Similarity NPD6099 Approved
0.7469 Intermediate Similarity NPD6100 Approved
0.7461 Intermediate Similarity NPD7701 Phase 2
0.746 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD3226 Approved
0.7451 Intermediate Similarity NPD1091 Approved
0.744 Intermediate Similarity NPD920 Approved
0.7425 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD7033 Discontinued
0.7407 Intermediate Similarity NPD3748 Approved
0.7403 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD6651 Approved
0.7385 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7385 Intermediate Similarity NPD7874 Approved
0.7374 Intermediate Similarity NPD7286 Phase 2
0.7371 Intermediate Similarity NPD7585 Approved
0.7354 Intermediate Similarity NPD7700 Phase 2
0.7354 Intermediate Similarity NPD7699 Phase 2
0.7353 Intermediate Similarity NPD7458 Discontinued
0.7347 Intermediate Similarity NPD7801 Approved
0.7342 Intermediate Similarity NPD6832 Phase 2
0.7342 Intermediate Similarity NPD4908 Phase 1
0.7338 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD8434 Phase 2
0.7333 Intermediate Similarity NPD6674 Discontinued
0.7333 Intermediate Similarity NPD1243 Approved
0.7325 Intermediate Similarity NPD2798 Approved
0.7321 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD7583 Approved
0.7317 Intermediate Similarity NPD2346 Discontinued
0.7317 Intermediate Similarity NPD2344 Approved
0.7305 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD2799 Discontinued
0.7289 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7287 Intermediate Similarity NPD4360 Phase 2
0.7287 Intermediate Similarity NPD4363 Phase 3
0.7278 Intermediate Similarity NPD9494 Approved
0.7262 Intermediate Similarity NPD7390 Discontinued
0.7261 Intermediate Similarity NPD1203 Approved
0.725 Intermediate Similarity NPD6798 Discontinued
0.725 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD2313 Discontinued
0.7244 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7243 Intermediate Similarity NPD8150 Discontinued
0.7234 Intermediate Similarity NPD6213 Phase 3
0.7234 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7234 Intermediate Similarity NPD6212 Phase 3
0.7229 Intermediate Similarity NPD1652 Phase 2
0.7226 Intermediate Similarity NPD1610 Phase 2
0.7225 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD8319 Approved
0.7216 Intermediate Similarity NPD8320 Phase 1
0.7195 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7191 Intermediate Similarity NPD5710 Approved
0.7191 Intermediate Similarity NPD5711 Approved
0.7168 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD7680 Approved
0.7151 Intermediate Similarity NPD5242 Approved
0.7151 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.715 Intermediate Similarity NPD7930 Approved
0.7143 Intermediate Similarity NPD5353 Approved
0.7143 Intermediate Similarity NPD2309 Approved
0.7143 Intermediate Similarity NPD3268 Approved
0.7126 Intermediate Similarity NPD6844 Discontinued
0.7118 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD5124 Phase 1
0.7117 Intermediate Similarity NPD6355 Discontinued
0.7117 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7113 Intermediate Similarity NPD5005 Approved
0.7113 Intermediate Similarity NPD5006 Approved
0.7112 Intermediate Similarity NPD6842 Approved
0.7112 Intermediate Similarity NPD6843 Phase 3
0.7112 Intermediate Similarity NPD6841 Approved
0.7099 Intermediate Similarity NPD6233 Phase 2
0.7078 Intermediate Similarity NPD1548 Phase 1
0.707 Intermediate Similarity NPD1608 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data